[Schnitzler syndrome: A dramatic improvement with anakinra].
Billey
Thierry
T
Beldjerd
Mounir
M
Popa
Luciana
L
Lassoued
Slim
S
D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D007145:Immunoglobulin kappa-Chains / Q000097:blood; D007279:Injections, Subcutaneous; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008297:Male; D017472:Receptors, Interleukin-1 / Q000819:agonists; D019873:Schnitzler Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D007075:Immunoglobulin M; D007145:Immunoglobulin kappa-Chains; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1